SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001438533-21-000010
Filing Date
2021-04-06
Accepted
2021-04-06 17:23:38
Documents
5
Period of Report
2021-04-06

Document Format Files

Seq Description Document Type Size
1 PRE 14A pre14aproxy2021prelim.htm PRE 14A 1256525
2 image0a041a.jpg GRAPHIC 8335
3 image2a021.jpg GRAPHIC 10405
4 image3a021.jpg GRAPHIC 10716
5 image4a021.jpg GRAPHIC 10976
  Complete submission text file 0001438533-21-000010.txt   1292277
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36257 | Film No.: 21810003
SIC: 2834 Pharmaceutical Preparations